BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8215790)

  • 1. [Protective effects of perindopril in an experimental model of cardiomyopathy].
    Chemla D; Scalbert E; Desché P; Pourny JC; Lambert F; Lecarpentier Y
    Arch Mal Coeur Vaiss; 1993 Feb; 86 Spec No 2():45-51. PubMed ID: 8215790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of perindopril on myocardial inotropy, lusitropy and economy, and on diaphragmatic contractility in the cardiomyopathic Syrian hamster.
    Chemla D; Scalbert E; Desche P; Pourny JC; Lambert F; Lecarpentier Y
    J Pharmacol Exp Ther; 1992 Aug; 262(2):516-25. PubMed ID: 1501112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial effects of early therapy with perindopril during experimental cardiomyopathy.
    Chemla D; Scalbert E; Desché P; Pourny JC; Lambert F; Lecarpentier Y
    Am J Cardiol; 1993 Jun; 71(17):41E-47E. PubMed ID: 8328367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin converting enzyme inhibition on crossbridge properties of diaphragm in cardiomyopathic hamsters of the dilated bio 53-58 strain.
    Lecarpentier Y; Coirault C; Lerebours G; Desche P; Scalbert E; Lambert F; Chemla D
    Am J Respir Crit Care Med; 1997 Feb; 155(2):630-6. PubMed ID: 9032205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of early and late therapy with perindopril on survival and myocardial inotropic state in experimental dilated cardiomyopathy.
    Chemla D; Scalbert E; Desché P; Lerebours G; Suard I; Lecarpentier Y
    J Cardiovasc Pharmacol; 1994 Jul; 24(1):151-7. PubMed ID: 7521480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired skeletal muscle performance in the early stage of cardiac pressure overload in rabbits: beneficial effects of angiotensin-converting enzyme inhibition.
    Coirault C; Langeron O; Lambert F; Blanc FX; Lerebours G; Claude N; Riou B; Chemla D; Lecarpentier Y
    J Pharmacol Exp Ther; 1999 Oct; 291(1):70-5. PubMed ID: 10490888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic alterations of diaphragm muscle in experimental cardiomyopathy.
    Lecarpentier Y; Pery N; Coirault C; Scalbert E; Desche P; Suard I; Lambert F; Chemla D
    Am Heart J; 1993 Sep; 126(3 Pt 2):770-6. PubMed ID: 8362752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiomyopathy in the Syrian hamster. Physiological and therapeutic aspects].
    Chemla D; Scalbert E; Desché P; Lecarpentier Y
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():85-7. PubMed ID: 1793330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relations between myocardial contractility, myosin phenotype, and plasma angiotensin-converting enzyme activity in the cardiomyopathic hamster.
    Lambert F; Lecarpentier Y; Lompré AM; Scalbert E; Desché P; Chemla D
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):410-5. PubMed ID: 7769806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
    Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA
    Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of shortening velocity, power, and acto-myosin crossbridge (CB) kinetics following long-term treatment with propionyl-L-carnitine, coenzyme Q10, and omega-3 fatty acids in BIO TO-2 cardiomyopathic Syrian hamsters papillary muscle.
    Vargiu R; Littarru GP; Fraschini M; Perinu A; Tiano L; Capra A; Mancinelli R
    Biofactors; 2010; 36(3):229-39. PubMed ID: 20533397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation status of regulatory proteins and functional characteristics in myocardium of dilated cardiomyopathy of Syrian hamsters.
    Ohnuki Y; Nishimura S; Sugiura S; Saeki Y
    J Physiol Sci; 2008 Feb; 58(1):15-20. PubMed ID: 18177543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of angiotensin II on intrinsic contractibility of the myocardium in the guinea pig].
    el Amrani AI; el Amrani F; Michel JB; Lecarpentier Y
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11):1587-92. PubMed ID: 1300956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of preload on myocardial relaxation in the rat].
    Chemla D; Lecarpentier Y; Clergue M; Hervé P; Brenot F; Hatt PY
    Arch Mal Coeur Vaiss; 1987 Dec; 80(13):1955-62. PubMed ID: 3130014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of alpha adrenergic stimulation on the mechanical properties of the myocardium].
    el Amrani AI; Riou B; Pourny JC; Lecarpentier Y
    Arch Mal Coeur Vaiss; 1990 Oct; 83(11):1751-5. PubMed ID: 1978652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormality in plasma catecholamines and myocardial adrenoceptors in cardiomyopathic BIO 53.58 Syrian hamsters and improvement by metoprolol treatment.
    Yamada S; Ohkura T; Yamadera T; Ito O; Kimura R; Nozawa Y; Hayashi S; Miyake H
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1389-95. PubMed ID: 9400015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The angiotensin-converting enzyme inhibitor perindopril in the treatment of congestive heart failure].
    Tereshchenko SN; Drozdov VN; Demidova IV; Levchuk NN; Moiseev VS
    Ter Arkh; 1997; 69(7):53-6. PubMed ID: 9424761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.